← All companies & organizations

Policy / Organization profile

Institute for Progress

What Institute for Progress does

The Institute for Progress (IFP) is a non-partisan Washington, D.C.-based think tank focused on innovation policy, working to “accelerate and shape the direction of scientific, technological, and industrial progress” in the United States. IFP describes its mission as policy entrepreneurship: producing research, providing technical assistance, and delivering policy advocacy aimed at shaping incentives and institutional practices across the U.S. science and technology ecosystem.

IFP organizes its work into multiple policy verticals. On its website, it highlights five main areas: Metascience (how to change incentives and institutions within science to produce more breakthrough research), High-Skilled Immigration (how to attract and retain top global talent), Biotechnology (policy aimed at preventing future pandemics and accelerating progress in the life sciences), Infrastructure (how to make it easier to build things in the world of atoms), and Emerging Technology (how to shape the frontier of technological development and deployment).

IFP’s recently published research emphasizes concrete policy proposals and government process improvements, including responses to federal rulemaking and guidance efforts (e.g., immigration fee policy and federal financial assistance grant-process reforms), as well as policy frameworks intended to influence how agencies pick priorities, structure programs, and allocate resources.

News

Company record

Sep 04, 2026 · Official · Institute for ProgressExplaining the Proposed $103k H-1B Fee

IFP published a Q&A on USCIS’s proposed $103,265 additional fee for cap-subject H-1B petitions, describing likely economic effects and addressing the fee’s legal basis and fiscal-law concerns; it also notes the publication’s public-comment timeline.

↗
Sep 04, 2026 · Official · Institute for ProgressWhy Biotech Companies Go to Australia to Test New Drugs

IFP published an analysis arguing that early-stage clinical trial initiation in Australia can be faster and at lower cost, and links this to the ability to reach Phase I more effectively without sacrificing safety.

↗
Aug 11, 2026 · Official · Institute for ProgressAmbitious American Science Requires Reliable and Effective Federal Funding

IFP published comments on an OMB proposed rule affecting federal financial assistance, arguing the proposal would destabilize federal financial assistance and degrade long-term planning for science.

↗
Aug 06, 2026 · Official · Institute for ProgressHow Should the US Prepare for Increasingly Automated AI R&D?

IFP published a report laying out criteria and policy recommendations for how the U.S. could respond to increasing automation in AI R&D, framed around minimizing downside if risks are low and/or providing strong benefits if risks are real.

↗
Aug 04, 2026 · Official · Institute for ProgressThe Success of the New Federal Housing Law Now Rests on States and Localities

IFP published a policy piece assessing the implementation needs of the 21st Century ROAD to Housing Act, focusing on how state and local reform decisions affect the flow of new federal funding to build more homes.

↗
Jul 30, 2026 · Official · Institute for ProgressExperience Matters

IFP published an implementer-focused guide on “Experience-Benchmarked prevailing wages” for the U.S. high-skilled immigration system.

↗
Jul 23, 2026 · Official · Institute for ProgressScience Agencies Need Metascience Units

IFP published a proposal for federal science agencies to create “metascience units” that can conduct experimentation and analysis to improve how agencies design and administer research funding mechanisms.

↗
Jul 17, 2026 · Official · Institute for ProgressPicking the Right Challenges for Genesis Mission

IFP published an evaluation of the Department of Energy’s Genesis Mission, recommending how to select priority areas and focus the initiative to improve chances of congressional support and more concrete outcomes.

↗
Show 2 earlier updates
Source map · 2 recurring channels · 36 references
Institute for ProgressOfficial Site · monitor↗MTS Frontier / Control RoomCurated Feed · monitor↗Official organization sourceOfficial Reference · reference↗34c031f8-c9fd-4018-8c5a-4159cdff6b0d-cdn-endpoint.azureedge.netReporting · reference↗apps.irs.govReporting · reference↗arxiv.orgReporting · reference↗careers.ips.usReporting · reference↗causeiq.comReporting · reference↗ccn.web.trReporting · reference↗ci.ashby.ma.usReporting · reference↗commons.wikimedia.orgReporting · reference↗ed.govReporting · reference↗eitc.irs.govReporting · reference↗en.wikipedia.orgReporting · reference↗fas.orgReporting · reference↗file990.zendesk.comReporting · reference↗forms.irs.govReporting · reference↗founderspledge.comReporting · reference↗grantedai.comReporting · reference↗i-ep.orgReporting · reference↗indianapolisfoundation.orgReporting · reference↗influencewatch.orgReporting · reference↗instituteforprogress.substack.comReporting · reference↗instrumentl.comReporting · reference↗irs.govReporting · reference↗jobs.ashbyhq.comReporting · reference↗jobs.energyimpactpartners.comReporting · reference↗legalclarity.orgReporting · reference↗linkedin.comReporting · reference↗nmlegis.govReporting · reference↗philanthropy.orgReporting · reference↗ppic.orgReporting · reference↗progress.comReporting · reference↗projects.propublica.orgReporting · reference↗rcfp.orgReporting · reference↗reddit.comReporting · reference↗sales.ashbyhq.comReporting · reference↗wikipedia.blackbriarcomputing.comReporting · reference↗

Still resolving: Newsroom · Official X

Funding

Latest disclosed valuationNot disclosed
Tracked capital$349K3 sourced rounds
DateRoundRaisedValuationLead / investorsEvidence
Jan 01, 2023Donation / Foundation grant (purpose disclosed by funder-data listing)$249K—
Not attributed
+1 investor
Jan 01, 2021Donation / Grant (reported as grant funding received; amount aggregated across reported years)$100K—
UndatedInstitutional philanthropic support (unrestricted majority; foundation donors listed)——

What it builds

  • Science
  • Technology
  • Industrial capacity
  • And innovation policy

Milestones & partnerships